Trial Profile
A Phase I Study of ZD1839 (Iressa) {IND#66,497} and Hypofractionated Thoracic Radiotherapy With Stereotactic Body Frame Immobilization for Patients With Advanced Non Small Cell Lung Cancer
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 01 Dec 2016
Price :
$35
*
At a glance
- Drugs Gefitinib (Primary)
- Indications Non-small cell lung cancer
- Focus Adverse reactions
- 07 Feb 2011 Actual end date (Sep 2010) added as reported by ClinicalTrials.gov.
- 07 Feb 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 04 Jun 2009 New trial record.